A new fingerprint ID device gives healthworkers access to accurate patient records.
Queensland scientists have found that non-invasive ultrasound technology can be used to treat Alzheimer’s disease and restore memory.
Google-backed genetic testing company 23andMe is launching its own drug development unit, betting that it can translate its database of customer DNA information into novel medicines.
Electric Ice Trays for Life Sciences from tecaLAB are an affordable option for easy bench top cooling. The compact Peltier design allows for maintenance free, constant cooling. Simply plug it in and cool to as low as 25C below ambient.
Basal cell carcinomas develop mutations in a protein on the Hedgehog pathway to evade a common drug therapy. Targeting another portion of the pathway may be an effective alternative treatment.
A new study reveals an important connection between dozens of genes that may contribute to autism, a major step toward understanding how brain development goes awry in some individuals with the disorder.
Findings could help shed light on Alzheimer's, Parkinson's, ALS and other diseases.
Kinetex EVO C18 columns from Phenomenex Inc. are the latest advancement in ultra-high performance HPLC columns.
Salk scientists re-engineered the bacterial defense system CRISPR to recognize HIV inside human cells and destroy the virus, offering a potential new therapy.
Discovery has implications for understanding epilepsy.
Prescription drugs spending jumped 13 percent last year, the biggest annual increase since 2003, according to the nation's largest pharmacy benefits manager.
Apple teamed up with a handful of universities to create these medical research applications.
In the ongoing Ebola outbreak in West Africa, whose death toll is approaching 10,000, little information has been available about how the human immune response unfolds after infection. Researchers have now obtained a first look at the immune responses in four Ebola virus disease survivors who received care at Emory University Hospital in 2014, by closely examining their T cells and B cells during the acute phase of the disease.
A new study led by UNC researchers identifies both where in the brain and how a protein in the brain, called Neuropeptide Y or NPY, can act to suppress binge alcohol drinking. These findings suggest that restoring NPY may be useful for treating alcohol use disorders and may also protect some individuals from becoming alcohol dependent.
Thermo Fisher Scientific introduced a new HPLC and UHPLC column for glycan analysis. This new column offers extremely high-resolution separations based on charge, isomerism, and size and is designed to facilitate both high resolution glycan profile characterization and quantification.